Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Nanotech Indonesia Global TbkISX:NANO +6.06%23 Net Current Asset Value is Rp0.00 as of . 20. GuruFocus rates ISX:NANO with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 571 Medical Devices & Instruments companies, PT Nanotech Indonesia Global Tbk ranks worse than 175131.17% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
The historical rank and industry rank for PT Nanotech Indonesia Global Tbk's Net Current Asset Value or its related term are showing as below:
ISX:NANO's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.31 * Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
PT Nanotech Indonesia Global Tbk (ISX:NANO) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
PT Nanotech Indonesia Global Tbk Net Current Asset Value Related Terms
PT Nanotech Indonesia Global Tbk Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Nanotech Indonesia Global Tbk Net Current Asset Value Chart
PT Nanotech Indonesia Global Tbk Annual Data
Trend
Net Current Asset Value
PT Nanotech Indonesia Global Tbk Semi-Annual Data
Net Current Asset Value
ISX:NANO vs ABT, SYK, MDT: Net Current Asset Value Comparison
For the Medical Devices subindustry, PT Nanotech Indonesia Global Tbk's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Nanotech Indonesia Global Tbk Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Nanotech Indonesia Global Tbk's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where PT Nanotech Indonesia Global Tbk's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of Rp0.00 mean?
PT Nanotech Indonesia Global Tbk (ISX:NANO) has a Net Current Asset Value of Rp0.00 as of . 20. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on PT Nanotech Indonesia Global Tbk and its competitors. According to the industry distribution chart, PT Nanotech Indonesia Global Tbk ranks #999999 out of 571 companies in the Medical Devices & Instruments industry.
Is PT Nanotech Indonesia Global Tbk's Net Current Asset Value too high?
PT Nanotech Indonesia Global Tbk's current Net Current Asset Value is Rp0.00. Based on the distribution chart, PT Nanotech Indonesia Global Tbk ranks #999999 out of 571 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PT Nanotech Indonesia Global Tbk has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does PT Nanotech Indonesia Global Tbk's Net Current Asset Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT Nanotech Indonesia Global Tbk ranks #999999 out of 571 companies for Net Current Asset Value. This places PT Nanotech Indonesia Global Tbk in the lower half of its industry. The industry median Net Current Asset Value is 5.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 5.31, based on 571 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on PT Nanotech Indonesia Global Tbk and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 5.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Nanotech Indonesia Global Tbk's current Net Current Asset Value is Rp0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Nanotech Indonesia Global Tbk stock overvalued right now?
PT Nanotech Indonesia Global Tbk (ISX:NANO) has a current Net Current Asset Value of Rp0.00. The current Net Current Asset Value is Rp0.00. PT Nanotech Indonesia Global Tbk's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For PT Nanotech Indonesia Global Tbk (ISX:NANO), the current Net Current Asset Value is Rp0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Nanotech Indonesia Global Tbk is a technology company that has a core business in the form of research and development-based technology and technology -based technology service (R&D), materials engineering, and nanotechnology. Its segments are Services and Sales. It generates the majority of its revenue from the Services segment.
23GF Score
Get the complete analysis for ISX:NANO
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:NANO has been successfully added to your 
